Even with eGFR ≥60 to <90, there was a decreasing trend in UACR, although it was not significant.
← all excerpts
Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study.
1
—
—